AstraZeneca Earnings Beat Estimates
- Trials of coronavirus vaccine underway in Brazil, South Africa
- Drugmaker to sell rich countries shots at profit post-pandemic
This article is for subscribers only.
Almost 10,000 people in the U.K. have been given an experimental Covid-19 vaccine from AstraZeneca Plc and the University of Oxford, a key step toward finding a shot that will help control the pandemic.
AstraZeneca is also well on its way to administering shots to 5,000 volunteers in a late-stage trial in Brazil and may scale up the size of its studies there, Chief Executive Officer Pascal Soriot said Thursday in an interview with Bloomberg TV. Subjects are being enrolled in South Africa, and a test in the U.S. is about to begin.